Paul Kelly, Radiation Oncologist at Bon Secours Hospital Cork UPMC, Ireland shared a post by Karen Molan, Senior Clinical Researcher at on X, adding:
“Great to make a contribution to this prostate cancer radiotherapy SBRT clinical trial, the subject of which is the role of Boston Scientific EMEA – Urology Space OAR Vue in modifying the risk of rectal side effects.
Patients are never the barrier to clinical trial recruitment.”
Quoting Karen Molan:
“Trial Activity.
SABRE Trial Achievement
20 Patients recruited.”